What’s next for 23andMe? Most people know the biotech company as a genetic testing service. Stories of people sending their cheek swabs off in the mail only to discover that a parent who raised them wasn’t their biological one have become a kind of millennial horror genre. Of course, most 23andMe experiences aren’t that dramatic: the company says over 14 million people have used the service in hopes of learning more about their ancestry.But this month, 23andMe revealed it is facing major financial troubles, ...

23andMe Co-Founder and CEO Anne Wojcicki speaks onstage during TechCrunch Disrupt SF 2017 at Pier 48 on September 19, 2017 in San Francisco, California.Shares of the genetic testing company 23andMe sank 21% Thursday, a day after the company reported dismal third-quarter fiscal 2024 results and discussed splitting itself in two to help juice its stock price.23andMe reported revenue of $45 million for the quarter, down from the $67 million it reported in the same period last year. The company said its net los ...

Shares of 23andMe Holding Co. fell 15.8% Thursday after the DNA-testing company fiscal third-quarter sales declined 33%, weighed down by lower consumer services and research revenue. The stock’s performance puts 23andMe ME, -17.19% shares on pace for their biggest daily percentage decline since Nov. 9, 2023, they fell 21.96%, according to Dow Jones Market Data. The stock is also on pace for its fourth-worst daily percentage decline. 23andMe’s third-quarter revenue was $44.7 million, down from $66.9 milli ...

23andMe Holding Co. (NASDAQ:ME) Q3 2024 Earnings Conference Call February 7, 2024 4:30 PM ET Company Participants Ian Cooney - Senior Director of Investor Relations Anne Wojcicki - Co-Founder and Chief Executive Officer Joseph Selsavage - Interim Chief Financial and Accounting Officer Jennifer Low - Head of Therapeutics Development Bill Richards - Head of Therapeutics Discovery Conference Call Participants Steven Mah - TD Cowen Operator Hello, and welcome to 23andMe's Fiscal Year 2024 Third Quarter Financia ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ____________________________________________ (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2023 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM___________ TO___________ Commission File Number 001-39587 __________________________________ ...

23andMe stock is down over 95% from its peak, cutting its value from $6 billion to $345 million. The genetic-testing company is facing financial and strategic challenges, and was hacked last year. The startup's backers, including Sequoia Capital, have taken big hits to their investments. NEW LOOK Sign up to get the inside scoop on today’s biggest stories in markets, tech, and business — delivered daily. Read preview Thanks for signing up! Access your favorite topics in a personalized feed while ...

23andMe Destroyed by Hackers and Losses Deagreez / iStock via Getty Images 23andMe Holding Co.’s (NASDAQ: ME) plans have come under attack by investors and the media after 23andMe stock collapsed in the past year. A major hack of its database and a tremendous loss have helped these attacks and cemented talk about its survival.The Wall Street Journal recently reported that 23andMe once had a market cap of $6 billion. That has dropped to $350 million. The paper points out that the company has tried using DN ...

23ME-01473 (‘1473) seeks to treat cancer by restoring anti-tumor immunity through NK and T cells‘1473 has dual mechanisms of blocking the immunosuppressive effects of soluble ULBP6, and inducing Fc receptor-mediated killing of ULBP6-expressing cancer cells through enhanced effector functionPhase 1 clinical study in patients with solid tumors to commence in H1 2024The target for ‘1473 was discovered through 23andMe's proprietary research platform, the world's largest recontactable database of de-identified h ...

SUNNYVALE, Calif., Jan. 30, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (NASDAQ:ME) (23andMe), a leading genetic health and biopharmaceutical company, announced a month-long initiative to amplify Ava DuVernay's new film ORIGIN and the film's groundbreaking Seat16 program. Seat16 allows anyone to gift $16 or more to purchase an ORIGIN movie ticket for a young person who might not otherwise be able to purchase a ticket to the film. For 23 days, 23andMe will donate 100 seats daily to support the program. ARRA ...

In a data breach notification letter filed with regulators this weekend, 23andMe revealed that hackers started breaking into customers’ accounts in April 2023 and continued through most of September.In other words, for around five months, 23andMe did not detect a series of cyberattacks where hackers were trying — and often succeeding — in brute-forcing access to customers’ accounts, according to a legally required filing 23andMe sent to California’s attorney general.Months after the hackers started targetin ...